In further support of a key role of GPR26 in regulating appetite, the GPR26 knockout mice exhibit hypersensitivity to treatment with rimonabant, an endocannabinoid receptor-1 antagonist commonly used to treat obesity by suppressing appetite in humans [34]. This evidence concerns the gene GPR26 and Obesity.